Giovanna Parmigiani

Giovanna Parmigiani

Auto-generated profile, based on publicly available information

Giovanna Parmigiani

Department of Human Neurosciences, Sapienza University of Rome, Rome, Italy

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
14 February 2022 in Neuropsychobiology
Verified
Journal Article
Closed access
PDF file
Antonio Del CasaleAntonio Del Casale
Antonio Del Casale
Stefano FerracutiStefano Ferracuti
Stefano Ferracuti
ABAndrea Steven Barbetti
Andrea Steven Barbetti
PBParide Bargagna
Paride Bargagna
PZPaolo Zega
Paolo Zega
MPMaurizio Pompili
Maurizio Pompili
Introduction: In recent years, research on posttraumatic stress disorder (PTSD) focused on the description of different biological correlates of illness. Morphological changes of different brain regions were involved in PTSD neurophysiopathology, being related to trauma or considered a resilience biomarker. In this meta-analysis, we aimed to investigate the grey matter changes reported in magnetic resonance imaging (MRI) studies on patients who have developed PTSD compared to exposed subjects who did not show a clinical PTSD onset. Methods: We meta-analysed eight peer-reviewed MRI studies conducted on trauma-exposed patients and reported results corrected for false positives. We then conducted global and intergroup comparisons from neuroimaging data of two cohorts of included subjects. The included studies were conducted on 250 subjects, including 122 patients with PTSD and 128 non-PTSD subjects exposed to trauma. Results: Applying a family-wise error correction, PTSD subjects compared to trauma-exposed non-PTSD individuals showed a significant volume reduction of a large left-sided grey matter cluster extended from the parahippocampal gyrus to the uncus, including the amygdala. Conclusions: These volumetric reductions are a major structural correlate of PTSD and can be related to the expression of symptoms. Future studies might consider these and other neural PTSD correlates, which may lead to the development of clinical applications for affected patients.

15 February 2021 in International Psychogeriatrics
Verified
Journal Article
Open access
PDF file
GPGiovanna Parmigiani
Giovanna Parmigiani
ACAntonio Del Casale
Antonio Del Casale
GMGabriele Mandarelli
Gabriele Mandarelli
BBBenedetta Barchielli
Benedetta Barchielli
GKGeorgios D. Kotzalidis
Georgios D. Kotzalidis
Stefano FerracutiStefano Ferracuti
Stefano Ferracuti
Objectives: To perform a meta-analysis of clinical studies on the differences in treatment or research decision-making capacity among patients with Mild Cognitive Impairment (MCI), Alzheimer’s disease (AD), and healthy comparisons (HCs). Design: A systematic search was conducted on Medline/Pubmed, CINAHL, PsycINFO, Web of Science, and Scopus. Standardized mean differences and random-effects model were used in all cases. Setting: The United States, France, Japan, and China. Participants: Four hundred and ten patients with MCI, 149 with AD, and 368 HCs were included. Measurements: The studies we included in the analysis assessed decisional capacity to consent by the MacArthur Competence Assessment Tool for Treatment (MAcCAT-T), MacArthur Competence Assessment Tool for Clinical Research (MacCAT-CR), Capacity to Consent to Treatment Instrument (CCTI), and University of California Brief Assessment of Capacity to Consent (UBACC). Results: We identified 109 potentially eligible studies from 1672 records, and 7 papers were included in the meta-analysis. The meta-analysis showed that there was significant impairment in a decision-making capacity in MCI patients compared to the HCs group in terms of Understanding (SMD = −1.04, 95% CI: −1.31 to −0.77, P < 0.001; I2 = 52%, P = 0.07), Appreciation (SMD = −0.51, 95% CI: −0.66 to −0.36, P < 0.001; I2 = 0%, P = 0.97), and Reasoning (SMD = −0.62, 95% CI: −0.77, −0.47, P < 0.001; I2=0%, P =0.46). MCI patients scored significantly higher in Understanding (SMD = 1.50, 95% CI: 0.91, 2.09, P = 0.01, I2 = 78%, P = 0.00001) compared to patients affected by AD. Conclusions: Patients affected by MCI are at higher risk of impaired capacity to consent to treatment and research compared to HCs, despite being at lower risk compared to patients affected by AD. Clinicians and researchers need to carefully evaluate decisional capacity in MCI patients providing informed consent.

1 September 2019 in International Journal of Law and Psychiatry
Verified
Journal Article
Closed access
GMGabriele Mandarelli
Gabriele Mandarelli
FCFelice Carabellese
Felice Carabellese
AFAlan R. Felthous
Alan R. Felthous
GPGiovanna Parmigiani
Giovanna Parmigiani
Antonio Del CasaleAntonio Del Casale
Antonio Del Casale
Stefano FerracutiStefano Ferracuti
Stefano Ferracuti

26 May 2020 in Journal of Forensic Sciences
Verified
Journal Article
Closed access
PDF file
FCFelice Carabellese
Felice Carabellese
AFAlan R. Felthous
Alan R. Felthous
GMGabriele Mandarelli
Gabriele Mandarelli
DMDomenico Montalbò
Domenico Montalbò
DTDonatella La Tegola
Donatella La Tegola
RCRoberto Catanesi
Roberto Catanesi

22 December 2015 in Journal of Forensic Sciences
Verified
Journal Article
Closed access
PDF file
GPGiovanna Parmigiani
Giovanna Parmigiani
GMGabriele Mandarelli
Gabriele Mandarelli
CDClaudia Dacquino
Claudia Dacquino
PPPieritalo Pompili
Pieritalo Pompili
GCGiovanni Lelli Chiesa
Giovanni Lelli Chiesa
Stefano FerracutiStefano Ferracuti
Stefano Ferracuti

17 February 2021 in International Review of Psychiatry
Verified
Journal Article
Open access
Stefano FerracutiStefano Ferracuti
Stefano Ferracuti
GPGiovanna Parmigiani
Giovanna Parmigiani
RCRoberto Catanesi
Roberto Catanesi
AVAntonio Ventriglio
Antonio Ventriglio
Christian NapoliChristian Napoli
Christian Napoli
GMGabriele Mandarelli
Gabriele Mandarelli
Involuntary psychiatric hospitalisation in Italy raises some critical forensic issues. We analysed the sociodemographic, psychopathological, and behavioural characteristics of involuntarily hospitalised psychiatric patients, and the effectiveness of the juridical procedure of guarantee. Case files (n = 2796) related to involuntary psychiatric hospitalisation (IPH) at the Office of the Tutelary Judge of the Ordinary Court of Rome (Italy) between January 2013 and May 2016 were analysed. For each case file sociodemographic, clinical and procedural information were collected. The sample included 53.7% men, patients had a mean age of 41.8 +/- 13.9. Most of the IPH proposal certificates reported more than one reason, among which the most frequent were symptoms referring to a psychotic dimension (54.8%), agitation (38.0%), and symptoms of bipolar and related disorders (26.3%) Female patients showed a higher prevalence of symptoms of the bipolar spectrum (F = 29.7%,M = 23.3%;p < 0.05), while male patients showed a higher prevalence of aggressive behaviour (F = 7.7%,M = 12.6%;p < 0.01). Over 85% of the IPH proposal certificates did not explicitly mention issues related to adherence to care, which is the second criterium requested for IH (treatment refusal) and up to 7.3% of the proposals were not properly motivated. However, only 0.8% cases were not validated by the Tutelary Judge. Possible issues in the IPH procedures emerged since a significant number of certifications showed poor concordance with law- criteria for involuntary psychiatric hospitalisation. Despite this evidence, the low rate of unvalidated procedures by the Tutelary Judge, suggests a possible limitation of this form of guarantee.